[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives

Abstract : Functional imaging using 18-fluorodeoxyglycose ([18F]FDG) positron emission tomography combined with computed tomography (PET/CT) has become a major imaging modality in Hodgkin lymphoma. This imaging modality allows for a significant improvement in staging, increased sensitivity, which involves differentiating residual tumors from fibrosis during assessment, and highly impacts treatment decisions into new PET-driven strategies. This review presents the main scientific data concerning the current applications of [18F]FDG-PET/CT in Hodgkin lymphoma at baseline, interim, and the end of treatment evaluation along with the main PET-driven trials for therapeutic decisions. The emergence of total metabolic tumor volume as a new functional prognostic factor will also be discussed.
Type de document :
Article dans une revue
Liste complète des métadonnées

Contributeur : Lnc - Université de Bourgogne <>
Soumis le : mercredi 14 novembre 2018 - 17:09:25
Dernière modification le : vendredi 11 octobre 2019 - 20:23:29

Lien texte intégral



Salim Kanoun, Cédric Rossi, Olivier Casasnovas. [18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives. Cancers, MDPI, 2018, 10 (5), pp.145. ⟨10.3390/cancers10050145⟩. ⟨hal-01922795⟩



Consultations de la notice